Euvifor; 7491-74-9; 2-Pyrrolidoneacetamide; Myocalm; Gabacet; UCB 6215; Spectrum_001421; Spectrum3_001523; 2-Oxo-1-pyrrolidineacetamide; CAS-7491-74-9; 1-Pyrrolidineacetamide, 2-oxo-; 5-21-06-00360 (Beilstein Handbook Reference); Cl-871; Naofukang [Chinese]; 2-Oxo-pyrrolidine acetamide; NCGC00015821-02; Piracetam; NCGC00015821-01; EU-0100949; DivK1c_000259; Pirroxil; KBio3_002406; Piracetamum [INN-Latin]; MLS000069719; 2-Pyrrolidinoneacetamide; KBio2_007037; NINDS_000259; Myocalm (TN); SPBio_002474; 2-Ketopyrrolidine-1-ylacetamide; Prestwick0_000537; AE-641/30117005; KBio2_001901; KBio1_000259; Nootropil; Lopac-P-5295; KBioGR_001064; Ciclofalina; KBioSS_001901; Prestwick_870; BRN 1526393; Spectrum2_001074; Piracetam (JAN/USAN); Nootropyl; Pyramem; SMR000058196; 1-Acetamido-2-pyrrolidinone; Genogris; Piracetam [USAN:BAN:INN]; KT-801; Pyracetam; ZINC03812874; Nootron; Normabrain; 2-Oxo-pyrrolidin-1-ylacetamide; KBio2_004469; Spectrum4_000742; D01914; SPBio_001088; Prestwick1_000537; EINECS 231-312-7
show less «
